The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-07

AUTHORS

Anthony El-Khoueiry, James A. Posey, Juan Ramón Castillo Ferrando, Smitha S. Krishnamurthi, Shariq Syed, Georgia Kollia, Ian Walters, Bruce S. Fischer, Eric Masson

ABSTRACT

PURPOSE: Hepatic impairment may impede tyrosine kinase inhibitor metabolism. This phase I study compared the pharmacokinetics of brivanib in patients with hepatocellular carcinoma (HCC) and varying levels of hepatic impairment with those with non-HCC malignancies and normal liver function. METHODS: Patients were assigned to the following groups: Groups A, B, and C (HCC plus mild, moderate, or severe hepatic impairment, respectively) and Group D (non-HCC malignancy and normal hepatic function). Brivanib alaninate (brivanib prodrug) doses were 400 mg in Groups A, B, and D and 200 mg in Group C. Brivanib exposure was determined on day 1 (single dose) and day 28 (multiple doses). RESULTS: Twenty-four patients participated in the study. After a single brivanib alaninate dose, brivanib exposure was comparable between Groups A, B, and D. Area under the concentration-time curve was 50 % higher in Group C versus Group D. There were not enough data to draw conclusions on multiple doses. Safety profile in Groups A, B, and D was consistent with previous brivanib monotherapy experience. Tolerability could not be assessed in Group C because of dose interruptions and discontinuations, generally due to the disease natural history. CONCLUSIONS: Brivanib exposure was similar in patients with HCC and mild or moderate hepatic impairment (Child-Pugh [CP] A or B status) and those with non-HCC malignancies and normal hepatic function, suggesting dose adjustment is unnecessary with CP A or B status. Experience with HCC and severe hepatic impairment (CP C status) is insufficient to recommend brivanib use in this population. More... »

PAGES

53-64

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-013-2168-z

DOI

http://dx.doi.org/10.1007/s00280-013-2168-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022770233

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23719718


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatic Insufficiency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Dropouts", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prodrugs", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Fibroblast Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Vascular Endothelial Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triazines", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Southern California", 
          "id": "https://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Suite 3440, 90033, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "El-Khoueiry", 
        "givenName": "Anthony", 
        "id": "sg:person.0773171377.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773171377.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Alabama at Birmingham", 
          "id": "https://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Posey", 
        "givenName": "James A.", 
        "id": "sg:person.01274560204.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274560204.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinical Assay Unit Phase I\u2013II, Virgen del Roc\u00edo University Hospital, Seville University, Seville, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Castillo Ferrando", 
        "givenName": "Juan Ram\u00f3n", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Case Western Reserve University", 
          "id": "https://www.grid.ac/institutes/grid.67105.35", 
          "name": [
            "Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krishnamurthi", 
        "givenName": "Smitha S.", 
        "id": "sg:person.01030400115.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030400115.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Piscataway, New Jersey, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Syed", 
        "givenName": "Shariq", 
        "id": "sg:person.01334614301.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334614301.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Princeton, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kollia", 
        "givenName": "Georgia", 
        "id": "sg:person.01150205302.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150205302.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Princeton, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walters", 
        "givenName": "Ian", 
        "id": "sg:person.0753251160.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753251160.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Princeton, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fischer", 
        "givenName": "Bruce S.", 
        "id": "sg:person.01306467014.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306467014.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bristol-Myers Squibb (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419971.3", 
          "name": [
            "Bristol-Myers Squibb, Princeton, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masson", 
        "givenName": "Eric", 
        "id": "sg:person.014363567577.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014363567577.38"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1124/dmd.110.037341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002991872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9440(10)64325-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006358837"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1349-7006.2007.00432.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012138361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013847179", 
          "https://doi.org/10.1038/nrc2442"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.111.042457", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016794704"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-09-0472", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021242839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-0509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022697644"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025760788", 
          "https://doi.org/10.1038/nrc2780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025760788", 
          "https://doi.org/10.1038/nrc2780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hep.510280322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026753162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-1991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028087376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2003.12.049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032013998"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2004.09.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035011181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2005.09.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040672904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ccr.2005.09.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040672904"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-10-2011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042620157"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.110.033951", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043803559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-009-1002-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045758798", 
          "https://doi.org/10.1007/s00280-009-1002-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-009-1002-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045758798", 
          "https://doi.org/10.1007/s00280-009-1002-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-009-1002-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045758798", 
          "https://doi.org/10.1007/s00280-009-1002-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0708857", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053513212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm051106d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055949982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm051106d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055949982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0030-1247133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057213264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/blr.2006.25.447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059238419"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138920009788897975", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069175829"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/156800909789057006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069190976"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083184753", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-07", 
    "datePublishedReg": "2013-07-01", 
    "description": "PURPOSE: Hepatic impairment may impede tyrosine kinase inhibitor metabolism. This phase I study compared the pharmacokinetics of brivanib in patients with hepatocellular carcinoma (HCC) and varying levels of hepatic impairment with those with non-HCC malignancies and normal liver function.\nMETHODS: Patients were assigned to the following groups: Groups A, B, and C (HCC plus mild, moderate, or severe hepatic impairment, respectively) and Group D (non-HCC malignancy and normal hepatic function). Brivanib alaninate (brivanib prodrug) doses were 400 mg in Groups A, B, and D and 200 mg in Group C. Brivanib exposure was determined on day 1 (single dose) and day 28 (multiple doses).\nRESULTS: Twenty-four patients participated in the study. After a single brivanib alaninate dose, brivanib exposure was comparable between Groups A, B, and D. Area under the concentration-time curve was 50 % higher in Group C versus Group D. There were not enough data to draw conclusions on multiple doses. Safety profile in Groups A, B, and D was consistent with previous brivanib monotherapy experience. Tolerability could not be assessed in Group C because of dose interruptions and discontinuations, generally due to the disease natural history.\nCONCLUSIONS: Brivanib exposure was similar in patients with HCC and mild or moderate hepatic impairment (Child-Pugh [CP] A or B status) and those with non-HCC malignancies and normal hepatic function, suggesting dose adjustment is unnecessary with CP A or B status. Experience with HCC and severe hepatic impairment (CP C status) is insufficient to recommend brivanib use in this population.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-013-2168-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "72"
      }
    ], 
    "name": "The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases", 
    "pagination": "53-64", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6c7b4e0cc29f6ade044c2c9fdbe281f589aa08d4634d4ec502cee75f9ee82364"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23719718"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-013-2168-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022770233"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-013-2168-z", 
      "https://app.dimensions.ai/details/publication/pub.1022770233"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T22:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000512.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00280-013-2168-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2168-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2168-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2168-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-013-2168-z'


 

This table displays all metadata directly associated to this object as RDF triples.

300 TRIPLES      21 PREDICATES      75 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-013-2168-z schema:about N06dc43150860459a81d3ab307c97dc4e
2 N09ff7ea197ae454a8ad126840e61efbd
3 N0bd942711d2d42ef8c6b1fd7814f288e
4 N0c348091c80441e3824dfebb737a4695
5 N3858ef59a15341e9b919abf897dafa4f
6 N4a4bfeb679504a5da7b5ec5b6b3b55af
7 N4ea91029917a4ad99015776934624c1c
8 N5a53dda711e6427d982d7d0aebed38cc
9 N5db5d588a5014874bfa85b14fe8534e7
10 N68d40f29259f48ed8de7081308afd089
11 N78adf7714edd4824a02210745a29ca3c
12 N84a9c4fb25d74bc484a575969f10871c
13 N8cc78d8e558b4dad9050c0501e6a9b0e
14 N9031de4490e8443e9bddc39398392e53
15 N9c7f88ce8e174fee964cfffe63a44bf2
16 Na26bd7c8e85e4faf95b90e4b37197a33
17 Nb9e0c07236234408bd13e8aabc1201d4
18 Nbb67911caecc4521b5b00beac067c565
19 Nc5fbdbd7962c41c2ac5f258ab8c2062c
20 Nd3c7e160305445f2a0e1a1f931608067
21 Nf33527a2040049959d1b47f58c42f48c
22 Nf5c928f03ffe4e26b776e2d3d46085b5
23 Nf65d700d6b48441abe18a2abce1e080b
24 anzsrc-for:11
25 anzsrc-for:1103
26 schema:author N8527129b2e08499a902731b0fd0a94bc
27 schema:citation sg:pub.10.1007/s00280-009-1002-0
28 sg:pub.10.1038/nrc2442
29 sg:pub.10.1038/nrc2780
30 https://app.dimensions.ai/details/publication/pub.1083184753
31 https://doi.org/10.1002/hep.510280322
32 https://doi.org/10.1016/j.ccr.2005.09.005
33 https://doi.org/10.1016/s0002-9440(10)64325-8
34 https://doi.org/10.1021/jm051106d
35 https://doi.org/10.1053/j.gastro.2003.12.049
36 https://doi.org/10.1053/j.gastro.2004.09.014
37 https://doi.org/10.1055/s-0030-1247133
38 https://doi.org/10.1056/nejmoa0708857
39 https://doi.org/10.1089/blr.2006.25.447
40 https://doi.org/10.1111/j.1349-7006.2007.00432.x
41 https://doi.org/10.1124/dmd.110.033951
42 https://doi.org/10.1124/dmd.110.037341
43 https://doi.org/10.1124/dmd.111.042457
44 https://doi.org/10.1158/1078-0432.ccr-08-0509
45 https://doi.org/10.1158/1078-0432.ccr-10-2011
46 https://doi.org/10.1158/1078-0432.ccr-11-1991
47 https://doi.org/10.1158/1535-7163.mct-09-0472
48 https://doi.org/10.2174/138920009788897975
49 https://doi.org/10.2174/156800909789057006
50 schema:datePublished 2013-07
51 schema:datePublishedReg 2013-07-01
52 schema:description PURPOSE: Hepatic impairment may impede tyrosine kinase inhibitor metabolism. This phase I study compared the pharmacokinetics of brivanib in patients with hepatocellular carcinoma (HCC) and varying levels of hepatic impairment with those with non-HCC malignancies and normal liver function. METHODS: Patients were assigned to the following groups: Groups A, B, and C (HCC plus mild, moderate, or severe hepatic impairment, respectively) and Group D (non-HCC malignancy and normal hepatic function). Brivanib alaninate (brivanib prodrug) doses were 400 mg in Groups A, B, and D and 200 mg in Group C. Brivanib exposure was determined on day 1 (single dose) and day 28 (multiple doses). RESULTS: Twenty-four patients participated in the study. After a single brivanib alaninate dose, brivanib exposure was comparable between Groups A, B, and D. Area under the concentration-time curve was 50 % higher in Group C versus Group D. There were not enough data to draw conclusions on multiple doses. Safety profile in Groups A, B, and D was consistent with previous brivanib monotherapy experience. Tolerability could not be assessed in Group C because of dose interruptions and discontinuations, generally due to the disease natural history. CONCLUSIONS: Brivanib exposure was similar in patients with HCC and mild or moderate hepatic impairment (Child-Pugh [CP] A or B status) and those with non-HCC malignancies and normal hepatic function, suggesting dose adjustment is unnecessary with CP A or B status. Experience with HCC and severe hepatic impairment (CP C status) is insufficient to recommend brivanib use in this population.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree false
56 schema:isPartOf N2e2f5311d6fc4d7cae068e586a966ba6
57 Na949e53b7ff7424c99e1cb31d4e42e90
58 sg:journal.1088364
59 schema:name The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
60 schema:pagination 53-64
61 schema:productId N6128c722c897440eb8fc55031f99ef1a
62 N6d4f77e7db4b42bf8d1cc127c7f6dc1e
63 N7a5aa4e2b5b14280b61e99813d6fdbab
64 Nb3adf12626d243d38fa42846751fee88
65 Nf0652c8206494332893f1eaece326a33
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022770233
67 https://doi.org/10.1007/s00280-013-2168-z
68 schema:sdDatePublished 2019-04-10T22:31
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N73d6f918bbf3437baa5bcc0b5ea25b0c
71 schema:url http://link.springer.com/10.1007%2Fs00280-013-2168-z
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N06dc43150860459a81d3ab307c97dc4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Prodrugs
77 rdf:type schema:DefinedTerm
78 N09ff7ea197ae454a8ad126840e61efbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Triazines
80 rdf:type schema:DefinedTerm
81 N0bcd58ffd8524cf69870ba9a79d7641e schema:name Piscataway, New Jersey, USA
82 rdf:type schema:Organization
83 N0bd942711d2d42ef8c6b1fd7814f288e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Metabolic Clearance Rate
85 rdf:type schema:DefinedTerm
86 N0c348091c80441e3824dfebb737a4695 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Hepatic Insufficiency
88 rdf:type schema:DefinedTerm
89 N0d94c1ee1b4246d09903fb1673ada18f rdf:first sg:person.01030400115.74
90 rdf:rest Ne7d4fcfd9d0d4093abb0687690b8faac
91 N217d55fade1a4aae8af6be9234c18a33 rdf:first N34b8eaab0acd4d149e6405ed7a62f6fd
92 rdf:rest N0d94c1ee1b4246d09903fb1673ada18f
93 N27ac681b8f424849800a76157abb1b88 rdf:first sg:person.01150205302.12
94 rdf:rest Nfbf3d7868cb048cc98ad4c85dea8a365
95 N2e2f5311d6fc4d7cae068e586a966ba6 schema:issueNumber 1
96 rdf:type schema:PublicationIssue
97 N34b8eaab0acd4d149e6405ed7a62f6fd schema:affiliation N762b3306cb4f4c518d8b84ea5f35eab9
98 schema:familyName Castillo Ferrando
99 schema:givenName Juan Ramón
100 rdf:type schema:Person
101 N375a84eaaa23410fab7cfba4fa339a86 rdf:first sg:person.01274560204.44
102 rdf:rest N217d55fade1a4aae8af6be9234c18a33
103 N3858ef59a15341e9b919abf897dafa4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Aged
105 rdf:type schema:DefinedTerm
106 N4a4bfeb679504a5da7b5ec5b6b3b55af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Liver Neoplasms
108 rdf:type schema:DefinedTerm
109 N4ea91029917a4ad99015776934624c1c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Carcinoma, Hepatocellular
111 rdf:type schema:DefinedTerm
112 N5a53dda711e6427d982d7d0aebed38cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Antineoplastic Agents
114 rdf:type schema:DefinedTerm
115 N5db5d588a5014874bfa85b14fe8534e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Patient Dropouts
117 rdf:type schema:DefinedTerm
118 N5f2135d1c24a4042b2771eca8b12cbf2 rdf:first sg:person.01306467014.27
119 rdf:rest Nbbba357ad3284b3eb682bc3ec3a860a2
120 N6128c722c897440eb8fc55031f99ef1a schema:name readcube_id
121 schema:value 6c7b4e0cc29f6ade044c2c9fdbe281f589aa08d4634d4ec502cee75f9ee82364
122 rdf:type schema:PropertyValue
123 N68d40f29259f48ed8de7081308afd089 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Receptors, Vascular Endothelial Growth Factor
125 rdf:type schema:DefinedTerm
126 N6d4f77e7db4b42bf8d1cc127c7f6dc1e schema:name pubmed_id
127 schema:value 23719718
128 rdf:type schema:PropertyValue
129 N73d6f918bbf3437baa5bcc0b5ea25b0c schema:name Springer Nature - SN SciGraph project
130 rdf:type schema:Organization
131 N762b3306cb4f4c518d8b84ea5f35eab9 schema:name Clinical Assay Unit Phase I–II, Virgen del Rocío University Hospital, Seville University, Seville, Spain
132 rdf:type schema:Organization
133 N78adf7714edd4824a02210745a29ca3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Protein Kinase Inhibitors
135 rdf:type schema:DefinedTerm
136 N7a5aa4e2b5b14280b61e99813d6fdbab schema:name doi
137 schema:value 10.1007/s00280-013-2168-z
138 rdf:type schema:PropertyValue
139 N84a9c4fb25d74bc484a575969f10871c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Severity of Illness Index
141 rdf:type schema:DefinedTerm
142 N8527129b2e08499a902731b0fd0a94bc rdf:first sg:person.0773171377.12
143 rdf:rest N375a84eaaa23410fab7cfba4fa339a86
144 N8cc78d8e558b4dad9050c0501e6a9b0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Liver
146 rdf:type schema:DefinedTerm
147 N9031de4490e8443e9bddc39398392e53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Middle Aged
149 rdf:type schema:DefinedTerm
150 N9c7f88ce8e174fee964cfffe63a44bf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Male
152 rdf:type schema:DefinedTerm
153 Na26bd7c8e85e4faf95b90e4b37197a33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 Na949e53b7ff7424c99e1cb31d4e42e90 schema:volumeNumber 72
157 rdf:type schema:PublicationVolume
158 Nb3adf12626d243d38fa42846751fee88 schema:name nlm_unique_id
159 schema:value 7806519
160 rdf:type schema:PropertyValue
161 Nb9e0c07236234408bd13e8aabc1201d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Receptors, Fibroblast Growth Factor
163 rdf:type schema:DefinedTerm
164 Nbb67911caecc4521b5b00beac067c565 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Aged, 80 and over
166 rdf:type schema:DefinedTerm
167 Nbbba357ad3284b3eb682bc3ec3a860a2 rdf:first sg:person.014363567577.38
168 rdf:rest rdf:nil
169 Nc5fbdbd7962c41c2ac5f258ab8c2062c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Half-Life
171 rdf:type schema:DefinedTerm
172 Nd3c7e160305445f2a0e1a1f931608067 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Cohort Studies
174 rdf:type schema:DefinedTerm
175 Ne7d4fcfd9d0d4093abb0687690b8faac rdf:first sg:person.01334614301.44
176 rdf:rest N27ac681b8f424849800a76157abb1b88
177 Nf0652c8206494332893f1eaece326a33 schema:name dimensions_id
178 schema:value pub.1022770233
179 rdf:type schema:PropertyValue
180 Nf33527a2040049959d1b47f58c42f48c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Dose-Response Relationship, Drug
182 rdf:type schema:DefinedTerm
183 Nf5c928f03ffe4e26b776e2d3d46085b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Alanine
185 rdf:type schema:DefinedTerm
186 Nf65d700d6b48441abe18a2abce1e080b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Female
188 rdf:type schema:DefinedTerm
189 Nfbf3d7868cb048cc98ad4c85dea8a365 rdf:first sg:person.0753251160.05
190 rdf:rest N5f2135d1c24a4042b2771eca8b12cbf2
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
195 schema:name Clinical Sciences
196 rdf:type schema:DefinedTerm
197 sg:journal.1088364 schema:issn 0344-5704
198 1432-0843
199 schema:name Cancer Chemotherapy and Pharmacology
200 rdf:type schema:Periodical
201 sg:person.01030400115.74 schema:affiliation https://www.grid.ac/institutes/grid.67105.35
202 schema:familyName Krishnamurthi
203 schema:givenName Smitha S.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01030400115.74
205 rdf:type schema:Person
206 sg:person.01150205302.12 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
207 schema:familyName Kollia
208 schema:givenName Georgia
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150205302.12
210 rdf:type schema:Person
211 sg:person.01274560204.44 schema:affiliation https://www.grid.ac/institutes/grid.265892.2
212 schema:familyName Posey
213 schema:givenName James A.
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274560204.44
215 rdf:type schema:Person
216 sg:person.01306467014.27 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
217 schema:familyName Fischer
218 schema:givenName Bruce S.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306467014.27
220 rdf:type schema:Person
221 sg:person.01334614301.44 schema:affiliation N0bcd58ffd8524cf69870ba9a79d7641e
222 schema:familyName Syed
223 schema:givenName Shariq
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334614301.44
225 rdf:type schema:Person
226 sg:person.014363567577.38 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
227 schema:familyName Masson
228 schema:givenName Eric
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014363567577.38
230 rdf:type schema:Person
231 sg:person.0753251160.05 schema:affiliation https://www.grid.ac/institutes/grid.419971.3
232 schema:familyName Walters
233 schema:givenName Ian
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753251160.05
235 rdf:type schema:Person
236 sg:person.0773171377.12 schema:affiliation https://www.grid.ac/institutes/grid.42505.36
237 schema:familyName El-Khoueiry
238 schema:givenName Anthony
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0773171377.12
240 rdf:type schema:Person
241 sg:pub.10.1007/s00280-009-1002-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045758798
242 https://doi.org/10.1007/s00280-009-1002-0
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/nrc2442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013847179
245 https://doi.org/10.1038/nrc2442
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/nrc2780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025760788
248 https://doi.org/10.1038/nrc2780
249 rdf:type schema:CreativeWork
250 https://app.dimensions.ai/details/publication/pub.1083184753 schema:CreativeWork
251 https://doi.org/10.1002/hep.510280322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026753162
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1016/j.ccr.2005.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040672904
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1016/s0002-9440(10)64325-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006358837
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1021/jm051106d schema:sameAs https://app.dimensions.ai/details/publication/pub.1055949982
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1053/j.gastro.2003.12.049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032013998
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1053/j.gastro.2004.09.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035011181
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1055/s-0030-1247133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057213264
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1056/nejmoa0708857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053513212
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1089/blr.2006.25.447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059238419
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1111/j.1349-7006.2007.00432.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012138361
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1124/dmd.110.033951 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043803559
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1124/dmd.110.037341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002991872
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1124/dmd.111.042457 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016794704
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1158/1078-0432.ccr-08-0509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022697644
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1158/1078-0432.ccr-10-2011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042620157
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1158/1078-0432.ccr-11-1991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028087376
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1158/1535-7163.mct-09-0472 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021242839
284 rdf:type schema:CreativeWork
285 https://doi.org/10.2174/138920009788897975 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069175829
286 rdf:type schema:CreativeWork
287 https://doi.org/10.2174/156800909789057006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069190976
288 rdf:type schema:CreativeWork
289 https://www.grid.ac/institutes/grid.265892.2 schema:alternateName University of Alabama at Birmingham
290 schema:name University of Alabama at Birmingham, Birmingham, AL, USA
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.419971.3 schema:alternateName Bristol-Myers Squibb (United States)
293 schema:name Bristol-Myers Squibb, Princeton, NJ, USA
294 rdf:type schema:Organization
295 https://www.grid.ac/institutes/grid.42505.36 schema:alternateName University of Southern California
296 schema:name USC Norris Comprehensive Cancer Center, 1441 Eastlake Ave, Suite 3440, 90033, Los Angeles, CA, USA
297 rdf:type schema:Organization
298 https://www.grid.ac/institutes/grid.67105.35 schema:alternateName Case Western Reserve University
299 schema:name Case Western Reserve University/University Hospitals Case Medical Center, Cleveland, OH, USA
300 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...